GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Argent Biopharma Ltd (ASX:RGT) » Definitions » 9-Day RSI

Argent Biopharma (ASX:RGT) 9-Day RSI : 42.76 (As of Jun. 04, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Argent Biopharma 9-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2024-06-04), Argent Biopharma's 9-Day RSI is 42.76.

The industry rank for Argent Biopharma's 9-Day RSI or its related term are showing as below:

ASX:RGT's 9-Day RSI is ranked better than
73.54% of 1134 companies
in the Drug Manufacturers industry
Industry Median: 43.58 vs ASX:RGT: 42.76

Competitive Comparison of Argent Biopharma's 9-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Argent Biopharma's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Argent Biopharma's 9-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Argent Biopharma's 9-Day RSI distribution charts can be found below:

* The bar in red indicates where Argent Biopharma's 9-Day RSI falls into.



Argent Biopharma  (ASX:RGT) 9-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Argent Biopharma  (ASX:RGT) 9-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.


Argent Biopharma 9-Day RSI Related Terms

Thank you for viewing the detailed overview of Argent Biopharma's 9-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Argent Biopharma (ASX:RGT) Business Description

Traded in Other Exchanges
Address
295 Rokeby Road, Suite 1, Subiaco, WA, AUS, 6008
MGC Pharmaceuticals Ltd is a biopharma company with a Nature to Medicine strategy at the forefront of the emerging phytocannabinoid and plant-derived medicine markets. The company's mission is to build an innovative, global bio-pharma company providing standardized, affordable plant-derived medicines of the highest regulatory compliance for targeted global markets.

Argent Biopharma (ASX:RGT) Headlines

From GuruFocus

Royce Global Value Trust (NYSE: RGT) as of Sep 30, 2022

By PRNewswire PRNewswire 10-28-2022

Royce Global Value Trust (NYSE: RGT) as of Jul 31, 2022

By PRNewswire PRNewswire 08-31-2022

Royce Global Value Trust (NYSE: RGT) as of Feb 28, 2022

By PRNewswire PRNewswire 03-25-2022

Royce Global Value Trust (NYSE: RGT) as of Jan 31, 2023

By PRNewswire PRNewswire 02-27-2023

Royce Global Value Trust (NYSE: RGT) as of Apr 30, 2022

By PRNewswire PRNewswire 07-03-2022

Royce Global Value Trust (NYSE: RGT) as of Apr 30, 2022

By PRNewswire PRNewswire 07-13-2022

Royce Global Value Trust (NYSE: RGT) as of Jun 30, 2022

By PRNewswire PRNewswire 07-29-2022

Royce Global Value Trust (NYSE: RGT) as of Apr 30, 2022

By PRNewswire PRNewswire 06-13-2022